Allos Pharma
Manufacturing · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.allospharma.comRevenue
<$5 MillionIndustry
About Allos Pharma
Allos Pharma is a late-stage pharmaceutical company focused on developing targeted therapeutics for Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS). Their lead product, arbaclofen, aims to correct the underlying molecular pathophysiology of these neurodevelopmental disorders, demonstrating clinically meaningful improvements in social functioning and irritability. The company leverages decades of translational neuroscience and clinical experience to advance its pipeline of therapeutics. Allos Pharma is dedicated to delivering science-based treatments for underserved neurodevelopmental and neurological disorders.Explore more
Allos Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Allos Pharma
Compare insights from companies similar to Allos Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Allos Pharma Tech Stack
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Allos Pharma
Sign Up For FreeTo access detailed company insights
Allos Pharma is a late-stage pharmaceutical company focused on developing targeted therapeutics for Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS). Their lead product, arbaclofen, aims to correct the underlying molecular pathophysiology of these neurodevelopmental disorders, demonstrating clinically meaningful improvements in social fu... Read More
